4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 187,539 | 189,061 | 275,594 | 249,108 | 275,678 |
| Marketable Securities | 314,353 | 352,885 | 250,317 | 39,124 | 43,986 |
| TOTAL | $510,757 | $552,633 | $535,589 | $296,588 | $328,243 |
| Non-Current Assets | |||||
| PPE Net | 19,866 | 18,761 | 19,464 | 20,126 | 20,738 |
| Investments And Advances | 48,779 | 35,715 | 62,942 | 10,954 | 0 |
| Other Non-Current Assets | 24,626 | 13,008 | 11,889 | 12,223 | 12,632 |
| TOTAL | $93,271 | $67,484 | $94,295 | $43,303 | $33,370 |
| Total Assets | $604,028 | $620,117 | $629,884 | $339,891 | $361,613 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,924 | 3,431 | 4,217 | 3,515 | 4,713 |
| Accrued Expenses | 21,415 | 12,776 | 9,013 | 12,014 | 10,194 |
| TOTAL | $29,465 | $19,403 | $16,403 | $18,951 | $18,163 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 35 | N/A | N/A | 273 | 130 |
| Other Non-Current Liabilities | 20,335 | 11,056 | 11,598 | 12,139 | 12,420 |
| TOTAL | $21,615 | $12,374 | $12,920 | $13,111 | $13,516 |
| Total Liabilities | $51,080 | $31,777 | $29,323 | $32,062 | $31,679 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,228 | 51,970 | 51,703 | 49,778 | 42,754 |
| Common Shares | 5 | 5 | 5 | 4 | 4 |
| Retained earnings | -526,524 | -482,681 | -447,728 | -415,327 | -383,044 |
| Other shareholders' equity | 1,079 | -293 | -109 | 16 | 534 |
| TOTAL | $552,948 | $588,340 | $600,561 | $307,829 | $329,934 |
| Total Liabilities And Equity | $604,028 | $620,117 | $629,884 | $339,891 | $361,613 |